Åkerström, Magnus2014-04-042014-04-042014-04-04978-91-628-8923-4 (printed)978-91-628-9872-2 (e-pub)http://hdl.handle.net/2077/34823Cadmium is an environmental contaminant which accumulates in the kidney and can potentially affect human health at relatively low concentrations. Biomarkers such as cadmium in urine or blood are normally used to assess the body burden of cadmium. We studied the relationship between cadmium in urine, blood, and kidney by using 109 healthy environmentally exposed kidney donors. The variability in urinary cadmium excretion, its interpretation, and effects on the study design were further examined using repeated urinary samples from 30 non-smoking healthy men and women. The results showed a strong association between cadmium in urine and kidney (rp=0.7), with an excretion corresponding to a biological half-time of about 30 years. A kidney cadmium of 25 μg/g corresponded to a urinary cadmium of 0.42 μg/g creatinine (i.e. a urine to kidney ratio of 1:60). Previous estimates of the urine to kidney cadmium ratio (1:20) may thus underestimate the kidney cadmium at low urinary cadmium excretion. On average, 70% of the urinary cadmium excretion could be explained by kidney cadmium. Urinary cadmium excretion was also affected by cadmium in blood and urinary albumin excretion. There was a circadian rhythm in the urinary cadmium excretion over 24h, affecting both the interpretation of urinary cadmium measures and the appropriate study design. There was an association between urinary cadmium and urinary proteins within individuals. Hence, when urinary cadmium is used as a biomarker for cadmium body burden, normal short-term variability in renal function may result in an overestimation of the nephrotoxicity of cadmium.engcadmiumurinebloodkidneybiological half-timevariabilitybiomarkersdeterminantsstudy designtext